227 related articles for article (PubMed ID: 30741995)
21. Protein arginine methyltransferase 1 promoted the growth and migration of cancer cells in esophageal squamous cell carcinoma.
Zhou W; Yue H; Li C; Chen H; Yuan Y
Tumour Biol; 2016 Feb; 37(2):2613-9. PubMed ID: 26392112
[TBL] [Abstract][Full Text] [Related]
22. p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells.
Tweddle DA; Malcolm AJ; Cole M; Pearson AD; Lunec J
Am J Pathol; 2001 Jun; 158(6):2067-77. PubMed ID: 11395384
[TBL] [Abstract][Full Text] [Related]
23. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
Smith AG; Popov N; Imreh M; Axelson H; Henriksson M
J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910
[TBL] [Abstract][Full Text] [Related]
24. PRMT1 promotes the tumor suppressor function of p14
Repenning A; Happel D; Bouchard C; Meixner M; Verel-Yilmaz Y; Raifer H; Holembowski L; Krause E; Kremmer E; Feederle R; Keber CU; Lohoff M; Slater EP; Bartsch DK; Bauer UM
EMBO J; 2021 Jul; 40(13):e106777. PubMed ID: 33999432
[TBL] [Abstract][Full Text] [Related]
25. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
Liu HJ; Li GL; Lei PC
Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
[No Abstract] [Full Text] [Related]
26. Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis.
Choi MS; Yuk DY; Oh JH; Jung HY; Han SB; Moon DC; Hong JT
Anticancer Res; 2008; 28(6A):3777-84. PubMed ID: 19189664
[TBL] [Abstract][Full Text] [Related]
27. MYCN downregulates integrin alpha1 to promote invasion of human neuroblastoma cells.
Tanaka N; Fukuzawa M
Int J Oncol; 2008 Oct; 33(4):815-21. PubMed ID: 18813796
[TBL] [Abstract][Full Text] [Related]
28. Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
Liu LM; Sun WZ; Fan XZ; Xu YL; Cheng MB; Zhang Y
Cancer Res; 2019 Jun; 79(11):2865-2877. PubMed ID: 31015230
[TBL] [Abstract][Full Text] [Related]
29. High level MycN expression in non-MYCN amplified neuroblastoma is induced by the combination treatment nutlin-3 and doxorubicin and enhances chemosensitivity.
Peirce SK; Findley HW
Oncol Rep; 2009 Dec; 22(6):1443-9. PubMed ID: 19885598
[TBL] [Abstract][Full Text] [Related]
30. Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma.
Van Maerken T; Speleman F; Vermeulen J; Lambertz I; De Clercq S; De Smet E; Yigit N; Coppens V; Philippé J; De Paepe A; Marine JC; Vandesompele J
Cancer Res; 2006 Oct; 66(19):9646-55. PubMed ID: 17018622
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
[TBL] [Abstract][Full Text] [Related]
32. Curcumin induced G2/M cycle arrest in SK-N-SH neuroblastoma cells through the ROS-mediated p53 signaling pathway.
Ye Z; Chen D; Zheng R; Chen H; Xu T; Wang C; Zhu S; Gao X; Zhang J; Li D; Pang Y; Zhu B; Li Y; Jia W
J Food Biochem; 2021 Sep; 45(9):e13888. PubMed ID: 34331475
[TBL] [Abstract][Full Text] [Related]
33. PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells.
He L; Hu Z; Sun Y; Zhang M; Zhu H; Jiang L; Zhang Q; Mu D; Zhang J; Gu L; Yang Y; Pan FY; Jia S; Guo Z
DNA Repair (Amst); 2020 Nov; 95():102953. PubMed ID: 32861926
[TBL] [Abstract][Full Text] [Related]
34. A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
Montemurro L; Raieli S; Angelucci S; Bartolucci D; Amadesi C; Lampis S; Scardovi AL; Venturelli L; Nieddu G; Cerisoli L; Fischer M; Teti G; Falconi M; Pession A; Hrelia P; Tonelli R
Cancer Res; 2019 Dec; 79(24):6166-6177. PubMed ID: 31615807
[TBL] [Abstract][Full Text] [Related]
35. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.
Chang YI; Hua WK; Yao CL; Hwang SM; Hung YC; Kuan CJ; Leou JS; Lin WJ
J Biol Chem; 2010 Jul; 285(27):20595-606. PubMed ID: 20442406
[TBL] [Abstract][Full Text] [Related]
36. PRMT1 regulates tumor growth and metastasis of human melanoma via targeting ALCAM.
Li L; Zhang Z; Ma T; Huo R
Mol Med Rep; 2016 Jul; 14(1):521-8. PubMed ID: 27175582
[TBL] [Abstract][Full Text] [Related]
37. p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6.
Phalke S; Mzoughi S; Bezzi M; Jennifer N; Mok WC; Low DH; Thike AA; Kuznetsov VA; Tan PH; Voorhoeve PM; Guccione E
Nucleic Acids Res; 2012 Oct; 40(19):9534-42. PubMed ID: 22987071
[TBL] [Abstract][Full Text] [Related]
38. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
39. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
40. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]